[96a5a0]: / output / allTrials / identified / NCT04054531_identified.json

Download this file

318 lines (318 with data), 13.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
{
"info": {
"nct_id": "NCT04054531",
"official_title": "An Open-label, Phase II Study of KN046 Evaluating the Efficacy and Safety of KN046 Plus Platinum-based Doublet Chemotherapy as First Line Therapy in Advanced Non-small Cell Lung Cancer Subjects.",
"inclusion_criteria": "* Has a histologically or cytologically confirmed diagnosis of stage IV NSCLC;\n* Has not received prior systemic treatment for metastatic NSCLC;\n* Has measurable disease based on RECIST 1.1.\n* Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status.\n* Has adequate organ function.\n* Has provided tumor tissue from locations not radiated prior to biopsy.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Previous immunotherapy (e.g. anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways)\n* Previously untreated or symptomatic central nervous system (CNS) metastases\n* Has received a live-virus vaccination within 28 days of planned treatment start.\n* Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody and chemotherapy.\n* Has or had active autoimmune disease.",
"miscellaneous_criteria": "Key"
},
"inclusion_lines": [
{
"line": "* Has a histologically or cytologically confirmed diagnosis of stage IV NSCLC;",
"criterions": [
{
"exact_snippets": "histologically or cytologically confirmed diagnosis of stage IV NSCLC",
"criterion": "NSCLC diagnosis",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
},
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
}
]
},
{
"line": "* Has not received prior systemic treatment for metastatic NSCLC;",
"criterions": [
{
"exact_snippets": "Has not received prior systemic treatment",
"criterion": "prior systemic treatment for metastatic NSCLC",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Has measurable disease based on RECIST 1.1.",
"criterions": [
{
"exact_snippets": "Has measurable disease based on RECIST 1.1.",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "measurement standard",
"expected_value": "RECIST 1.1"
}
]
}
]
},
{
"line": "* Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status.",
"criterions": [
{
"exact_snippets": "performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Has adequate organ function.",
"criterions": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Has provided tumor tissue from locations not radiated prior to biopsy.",
"criterions": [
{
"exact_snippets": "provided tumor tissue",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "provision",
"expected_value": true
}
]
},
{
"exact_snippets": "locations not radiated prior to biopsy",
"criterion": "tumor tissue location",
"requirements": [
{
"requirement_type": "radiation status",
"expected_value": "not radiated prior to biopsy"
}
]
}
]
},
{
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Previous immunotherapy (e.g. anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways)",
"criterions": [
{
"exact_snippets": "Previous immunotherapy (e.g. anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways)",
"criterion": "previous immunotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previously untreated or symptomatic central nervous system (CNS) metastases",
"criterions": [
{
"exact_snippets": "Previously untreated ... central nervous system (CNS) metastases",
"criterion": "central nervous system (CNS) metastases",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "untreated"
}
]
},
{
"exact_snippets": "symptomatic central nervous system (CNS) metastases",
"criterion": "central nervous system (CNS) metastases",
"requirements": [
{
"requirement_type": "symptom presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has received a live-virus vaccination within 28 days of planned treatment start.",
"criterions": [
{
"exact_snippets": "Has received a live-virus vaccination within 28 days of planned treatment start.",
"criterion": "live-virus vaccination",
"requirements": [
{
"requirement_type": "time since vaccination",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
]
}
]
},
{
"line": "* Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody and chemotherapy.",
"criterions": [
{
"exact_snippets": "Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody",
"criterion": "hypersensitivity reaction to monoclonal antibody",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "temporal",
"expected_value": "previously"
}
]
},
{
"exact_snippets": "Previously had a severe hypersensitivity reaction to treatment with ... chemotherapy",
"criterion": "hypersensitivity reaction to chemotherapy",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "temporal",
"expected_value": "previously"
}
]
}
]
},
{
"line": "* Has or had active autoimmune disease.",
"criterions": [
{
"exact_snippets": "Has or had active autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [
{
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}